INTERNATIONAL PATENT: LYSINBIO CO., LTD., 주식회사 리신바이오 FILES APPLICATION FOR "RECOMBINANT ENDOLYSIN FOR INHIBITING PATHOGENIC GRAM-NEGATIVE BACTERIA AND USE THEREOF"

GENEVA, April 29 -- LYSINBIO CO., LTD. (226, 2nd floor, 187, Techno 2-roYuseong-guDaejeon 34025), 주식회사 리신바이오 (대전광역시유성구테크노2로 187, 2층 226호) filed a patent application (PCT/KR2024/014039) for "RECOMBINANT ENDOLYSIN FOR INHIBITING PATHOGENIC GRAM-NEGATIVE BACTERIA AND USE THEREOF" on Sep 13, 2024. With publication no. WO/2025/084631, the details related to the patent application was published on Apr 24, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO)....